Zaiou M - Search Results

1

Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels.

Benachour H, Zaiou M, Herbeth B, Lambert D, Lamont JV, Pfister M, Siest G, Tiret L, Blankenberg S, Fitzgerald PS, Visvikis-Siest S. Benachour H, et al. Among authors: zaiou m. Pharmacogenomics. 2009 Jun;10(6):951-9. doi: 10.2217/pgs.09.29. Pharmacogenomics. 2009. PMID: 19530962

2

A rapid and reliable method for direct genotyping of codon 360 in the human apolipoprotein A-IV gene.

Zaiou M, Visvikis S, Visvikis A, Siest G. Zaiou M, et al. J Lipid Res. 1992 Jul;33(7):1061-6. J Lipid Res. 1992. PMID: 1358994 Free article.

3

DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population.

Zaiou M, Visvikis S, Gueguen R, Parra HJ, Fruchart JC, Siest G. Zaiou M, et al. Clin Genet. 1994 Sep;46(3):248-54. doi: 10.1111/j.1399-0004.1994.tb04235.x. Clin Genet. 1994. PMID: 7820939

4

Sources of variability of human plasma apolipoprotein A-IV levels and relationships with lipid metabolism.

Zaiou M, Visvikis S, Gueguen R, Steinmetz J, Parra HJ, Fruchart JC, Siest G. Zaiou M, et al. Genet Epidemiol. 1994;11(2):101-14. doi: 10.1002/gepi.1370110202. Genet Epidemiol. 1994. PMID: 8013892

5

The role of genetics in defining reference values and health status.

Siest G, Visvikis S, Zaiou M, Régis A, Jaid M, Steinmetz J, Herbeth B, Artur Y, Schiele F, Gueguen R, et al. Siest G, et al. Among authors: zaiou m. Methods Inf Med. 1993 Apr;32(3):255-9. Methods Inf Med. 1993. PMID: 8341163

6

IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort.

Haddy N, Sass C, Droesch S, Zaiou M, Siest G, Ponthieux A, Lambert D, Visvikis S. Haddy N, et al. Among authors: zaiou m. Atherosclerosis. 2003 Oct;170(2):277-83. doi: 10.1016/s0021-9150(03)00287-9. Atherosclerosis. 2003. PMID: 14612208

7

The future of genetic and genomic medicine in health risk assessment and disease: a path toward individualized medicine.

Zaiou M. Zaiou M. Pharmacogenomics. 2005 Jan;6(1):7-12. doi: 10.1517/14622416.6.1.7. Pharmacogenomics. 2005. PMID: 15723600 No abstract available.

8

Genetic determinants of blood pressure regulation.

Marteau JB, Zaiou M, Siest G, Visvikis-Siest S. Marteau JB, et al. Among authors: zaiou m. J Hypertens. 2005 Dec;23(12):2127-43. doi: 10.1097/01.hjh.0000186024.12364.2e. J Hypertens. 2005. PMID: 16269952 Review.

9

Genetic profiling of human cell lines used as in vitro model to study cardiovascular pathophysiology and pharmacotoxicology.

Jeannesson E, Siest G, Zaiou M, Berrahmoune H, Masson C, Visvikis-Siest S. Jeannesson E, et al. Among authors: zaiou m. Cell Biol Toxicol. 2009 Dec;25(6):561-71. doi: 10.1007/s10565-008-9112-8. Epub 2008 Dec 7. Cell Biol Toxicol. 2009. PMID: 19067187

10

Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factors.

Benachour H, Zaiou M, Samara A, Herbeth B, Pfister M, Lambert D, Siest G, Visvikis-Siest S. Benachour H, et al. Among authors: zaiou m. Nutr Metab Cardiovasc Dis. 2009 Dec;19(10):720-8. doi: 10.1016/j.numecd.2009.01.001. Epub 2009 Apr 5. Nutr Metab Cardiovasc Dis. 2009. PMID: 19346112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters